文献速递骨肌介入神经CT

CT引导下氧气-臭氧(O2-O3)疗法治疗下背痛的疗效与安全性:一项回顾性单中心研究

Efficacy and safety of CT-guided oxygen-ozone (O2-O3) therapy for low back pain: a retrospective single-center study.
PubMed 文献 · Radiol Med · 2025-08-14

本研究为单中心回顾性观察研究,纳入2016年1月至2017年3月接受CT引导下O2-O3椎间盘内和/或小关节注射的下背痛患者123例,分为小关节骨关节炎组、单节段椎间盘突出伴单侧坐骨神经痛组和双节段椎间盘突出伴双侧或单侧坐骨神经痛组。治疗后3周VAS评分从基线7.5±1.2显著降至3.5±1.5(T=43.74,p<0.001),未报告并发症。作者认为结果强烈支持O2-O3疗法可提供显著短期疼痛缓解,但需进一步对照研究确认长期疗效并优化治疗方案。

要点

  • CT引导下O2-O3注射后3周VAS从7.5±1.2降至3.5±1.5(T=43.74,p<0.001)。
  • 21.95%患者VAS降低>4分,57.72%降低2-4分,18.7%降低≤1分。
  • 术后VAS组间比较:A组与B组、A组与C组差异显著(均p<0.001),B组与C组无显著差异(p=0.247)。

核心结论

  • 作者认为 findings 强烈支持O2-O3疗法治疗下背痛的疗效和安全性,可在不同患者亚组中提供显著短期疼痛缓解。
  • 作者提出需进一步对照研究以确认长期疗效并优化治疗方案。

研究设计与样本

  • 单中心回顾性观察研究,纳入2016年1月至2017年3月接受CT引导下O2-O3椎间盘内和/或小关节注射的下背痛患者123例。
  • 患者分为三组:A组为小关节骨关节炎,B组为单节段椎间盘突出伴单侧坐骨神经痛,C组为双节段椎间盘突出伴双侧或单侧坐骨神经痛。
  • 疼痛强度采用视觉模拟量表(VAS)在基线和末次注射后3周评估。
  • 统计分析采用配对t检验进行治疗前后比较,采用单因素方差分析和Tukey HSD进行组间比较。

诊断标准与关键数值

  • 全队列基线VAS为7.5±1.2,治疗后降至3.5±1.5(T=43.74,p<0.001)。
  • A组VAS从7.2±1.3降至3.8±1.4;B组从7.8±1.0降至3.2±1.3;C组从8.0±0.9降至3.0±1.2。
  • 治疗后VAS组间比较:F=27.36,p<0.001;Tukey HSD显示A组与B组差异显著(p<0.001),A组与C组差异显著(p<0.001),B组与C组无显著差异(p=0.247)。
  • 总体21.95%患者VAS降低>4分(显著改善),57.72%降低2-4分(中度改善),18.7%降低≤1分(轻微改善)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文结论提出需进一步对照研究以确认长期疗效并优化治疗方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Oxygen-ozone (O2-O3) therapy is increasingly recognized as a minimally invasive option for managing low back pain (LBP). This study aims to assess the efficacy and safety of CT-guided O2-O3 injections, both as a standalone therapy and in combination with other medications, across a diverse cohort of patients with LBP.

MATERIALS AND METHODS: We conducted a single-center retrospective observational study of patients with LBP who underwent CT-guided O2-O3 intradiscal and/or facet joint injections between January 2016 and March 2017. Patients were categorized into three groups: Group A (facet joint osteoarthritis), Group B (single-level disc herniation with unilateral sciatica), and Group C (double-level disc herniation with bilateral or unilateral sciatica). Pain intensity was assessed using the Visual Analog Scale (VAS) at baseline and three weeks after the final injection. Statistical analysis included paired t-tests for pre- and post-treatment comparisons and one-way ANOVA with Tukey's HSD for group comparisons.

RESULTS: A total of 123 patients were included. The mean baseline VAS score for the entire cohort was 7.5 ± 1.2, which significantly decreased to 3.5 ± 1.5 following treatment (T = 43.74, p < 0.001). In Group A, the mean VAS decreased from 7.2 ± 1.3 to 3.8 ± 1.4; in Group B, from 7.8 ± 1.0 to 3.2 ± 1.3; and in Group C, from 8.0 ± 0.9 to 3.0 ± 1.2. ANOVA revealed significant differences in post-treatment VAS scores among groups (F = 27.36, p < 0.001). Tukey's HSD indicated significant differences between Groups A and B (p < 0.001) and A and C (p < 0.001), with no significant difference between Groups B and C (p = 0.247). Overall, 21.95% of patients experienced significant improvement (VAS reduction > 4 points), 57.72% had moderate improvement (VAS reduction 2-4 points), and 18.7% showed minimal improvement (VAS reduction ≤ 1 point). No complications were reported during or after the procedures.

CONCLUSION: The findings strongly support the efficacy and safety of O2-O3 therapy for the treatment of LBP, offering significant short-term pain relief across diverse patient subgroups. Further controlled studies are warranted to confirm long-term efficacy and optimize treatment protocols.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Bellelli A, D'Andrea V, Pileri M, et al. Efficacy and safety of CT-guided oxygen-ozone (O2-O3) therapy for low back pain: a retrospective single-center study. Radiol Med. 2025. PMID: 40810890. doi:10.1007/s11547-025-02071-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。